Dorte Gyrd-Hansen

Author PubWeight™ 53.24‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effects coding in discrete choice experiments. Health Econ 2005 1.82
2 Societal views on orphan drugs: cross sectional survey of Norwegians aged 40 to 67. BMJ 2010 1.80
3 Number needed to treat: easily understood and intuitively meaningful? Theoretical considerations and a randomized trial. J Clin Epidemiol 2002 1.79
4 Influenza pandemic: perception of risk and individual precautions in a general population. Cross sectional study. BMC Public Health 2007 1.24
5 Danish GPs' perception of disease risk and benefit of prevention. Fam Pract 2002 1.19
6 Preference heterogeneity and choice of cardiac rehabilitation program: results from a discrete choice experiment. Health Policy 2007 1.15
7 International comparison of the definition and the practical application of health technology assessment. Int J Technol Assess Health Care 2005 1.14
8 Can postponement of an adverse outcome be used to present risk reductions to a lay audience? A population survey. BMC Med Inform Decis Mak 2007 1.11
9 Insensitivity to scope in contingent valuation studies: reason for dismissal of valuations? Appl Health Econ Health Policy 2012 1.08
10 Laypersons' understanding of relative risk reductions: randomised cross-sectional study. BMC Med Inform Decis Mak 2008 1.07
11 Conjoint analysis. The cost variable: an Achilles' heel? Health Econ 2003 1.06
12 Waist circumference and body mass index as predictors of health care costs. PLoS One 2008 1.05
13 Communicating risk using absolute risk reduction or prolongation of life formats: cluster-randomised trial in general practice. Br J Gen Pract 2014 1.05
14 Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial. Int J Cancer 2013 1.03
15 Preference for practice: a Danish study on young doctors' choice of general practice using a discrete choice experiment. Eur J Health Econ 2013 1.03
16 Time-trends in health technology assessments: an analysis of developments in composition of international health technology assessments from 1989 to 2002. Int J Technol Assess Health Care 2005 1.02
17 Ordering effect and price sensitivity in discrete choice experiments: need we worry? Health Econ 2006 0.99
18 Increasing participation in cervical cancer screening: telephone contact with long-term non-attendees in Sweden. Results from RACOMIP, a randomized controlled trial. Int J Cancer 2013 0.98
19 Comparing hospital costs: what is gained by accounting for more than a case-mix index? Soc Sci Med 2009 0.96
20 Do general practitioners know patients' preferences? An empirical study on the agency relationship at an aggregate level using a discrete choice experiment. Value Health 2012 0.93
21 Estimating the Danish populations' preferences for pharmacogenetic testing using a discrete choice experiment. The case of treating depression. Value Health 2008 0.93
22 Organisational determinants of production and efficiency in general practice: a population-based study. Eur J Health Econ 2011 0.92
23 Estimating a WTP-based value of a QALY: the 'chained' approach. Soc Sci Med 2013 0.91
24 General practitioners' preferences for the organisation of primary care: a discrete choice experiment. Health Policy 2012 0.90
25 Communicating effectiveness of intervention for chronic diseases: what single format can replace comprehensive information? BMC Med Inform Decis Mak 2008 0.89
26 Willingness to pay for allergy-vaccination among Danish patients with respiratory allergy. Int J Technol Assess Health Care 2010 0.87
27 Communicating treatment effectiveness in the context of chronic disease processes. Expert Rev Pharmacoecon Outcomes Res 2006 0.87
28 Trends in time to invasive examination and treatment from 2001 to 2009 in patients admitted first time with non-ST elevation myocardial infarction or unstable angina in Denmark. BMJ Open 2014 0.86
29 Medication effectiveness may not be the major reason for accepting cardiovascular preventive medication: a population-based survey. BMC Med Inform Decis Mak 2012 0.84
30 Do informal caregivers in mental illness feel more burdened? A comparative study of mental versus somatic illnesses. Scand J Public Health 2011 0.84
31 Economic costs of abdominal obesity. Obes Facts 2008 0.83
32 Patient related outcomes in a real life prospective follow up study: Allergen immunotherapy increase quality of life and reduce sick days. World Allergy Organ J 2013 0.83
33 Increasing marginal utility of small increases in life-expectancy? Results from a population survey. J Health Econ 2010 0.83
34 The impact of population ageing on future Danish drug expenditure. Health Policy 2005 0.82
35 Differences in general practice initiated expenditures across Danish local health authorities-A multilevel analysis. Health Policy 2009 0.81
36 Characteristics of patients receiving allergy vaccination: to which extent do socio-economic factors play a role? Eur J Public Health 2010 0.81
37 Patient preferences for pharmacogenetic screening in depression. Int J Technol Assess Health Care 2008 0.81
38 Radiation from mobile phone systems: Is it perceived as a threat to people's health? Bioelectromagnetics 2009 0.81
39 Exploring the relationship between costs and quality: does the joint evaluation of costs and quality alter the ranking of Danish hospital departments? Eur J Health Econ 2010 0.80
40 Short and long-term labour market consequences of coronary heart disease: a register-based follow-up study. Eur J Cardiovasc Prev Rehabil 2009 0.80
41 Willingness-to-pay for a population program aimed at reducing dietary salt in Denmark. Prev Med 2006 0.80
42 The influence of information and private versus public provision on preferences for screening for prostate cancer: a willingness-to-pay study. Health Policy 2011 0.80
43 Future costs in cost-effectiveness analysis: an empirical assessment. Eur J Health Econ 2010 0.80
44 Does the EQ-5D measure quality of life in schizophrenia? J Ment Health Policy Econ 2011 0.79
45 Costs of heart disease and risk behaviour: implications for expenditure on prevention. Scand J Public Health 2008 0.79
46 Effects of alternative styles of risk information on EMF risk perception. Bioelectromagnetics 2010 0.79
47 Individual decision making in relation to participation in cardiovascular screening: a study of revealed and stated preferences. Scand J Public Health 2013 0.79
48 Cost-effectiveness of alendronate in the prevention of osteoporotic fractures in Danish women. Basic Clin Pharmacol Toxicol 2005 0.78
49 Impact of effectiveness information format on patient choice of therapy and satisfaction with decisions about chronic disease medication: the "Influence of intervention Methodologies on Patient Choice of Therapy (IMPACT)" cluster-randomised trial in general practice. BMC Health Serv Res 2013 0.78
50 Does access to invasive examination and treatment influence socioeconomic differences in case fatality for patients admitted for the first time with non-ST-elevation myocardial infarction or unstable angina? EuroIntervention 2016 0.78
51 Are people who claim compensation "cured by a verdict"? A longitudinal study of health outcomes after whiplash. J Law Med 2012 0.77
52 [Obesity related health care costs assessed from BMI or waist circumference--secondary publication]. Ugeskr Laeger 2009 0.77
53 NNT is not easily understood. Fam Pract 2002 0.77
54 Prenatal screening for cystic fibrosis: an economic analysis. Health Econ 2002 0.76
55 Norwegian obstetricians' opinions about cesarean section on maternal request: should women pay themselves? Acta Obstet Gynecol Scand 2010 0.76
56 Investigating patients' preferences for cardiac rehabilitation in Denmark. Int J Technol Assess Health Care 2006 0.76
57 Handling value added tax (VAT) in economic evaluations: should prices include VAT? Appl Health Econ Health Policy 2006 0.76
58 [Association between productivity, list size, patient and practice characteristics in general practice]. Ugeskr Laeger 2010 0.75
59 Does the primary screening test influence women's anxiety and intention to screen for cervical cancer? A randomized survey of Norwegian women. BMC Public Health 2014 0.75
60 The concept of risk: a comment to Reventlow and co-workers. Scand J Prim Health Care 2002 0.75
61 Benign breast disease and breast cancer. N Engl J Med 2005 0.75
62 Cost-effectiveness analysis based on the number-needed-to-treat: common sense or non-sense? Health Econ 2004 0.75
63 [Prioritization and health--should maximum-price life years be introduced?]. Tidsskr Nor Laegeforen 2007 0.75
64 GPs as citizens' agents: prescription behavior and altruism. Eur J Health Econ 2008 0.75
65 The potential of smoking cessation programmes and a smoking ban in public places: comparing gain in life expectancy and cost effectiveness. Scand J Public Health 2011 0.75
66 [General practitioners' perception of disease risks and benefit of prevention]. Ugeskr Laeger 2002 0.75
67 Graded pairs comparison - does strength of preference matter? Analysis of preferences for specialised nurse home visits for pain management. Health Econ 2007 0.75
68 Do guidelines recommending pharmacogenetic testing of psychiatric patients affect treatment costs and the use of healthcare services? Scand J Public Health 2011 0.75
69 Valuation of morbidity and mortality risk reductions. Does context matter? Accid Anal Prev 2012 0.75